Crossmark

Accelerated identification of disease-causing variants with ultra-rapid nanopore genome sequencing

Crossref DOI link: https://doi.org/10.1038/s41587-022-01221-5

Published Online: 2022-03-28

Published Print: 2022-07

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Goenka, Sneha D. http://orcid.org/0000-0002-1716-7769
Gorzynski, John E. http://orcid.org/0000-0002-9034-9016
Shafin, Kishwar http://orcid.org/0000-0001-5252-3434
Fisk, Dianna G.

Pesout, Trevor

Jensen, Tanner D.

Monlong, Jean

Chang, Pi-Chuan http://orcid.org/0000-0003-3021-6446
Baid, Gunjan

Bernstein, Jonathan A. http://orcid.org/0000-0001-5369-346X
Christle, Jeffrey W.

Dalton, Karen P. http://orcid.org/0000-0003-2834-8001
Garalde, Daniel R.

Grove, Megan E. http://orcid.org/0000-0002-7972-0005
Guillory, Joseph

Kolesnikov, Alexey

Nattestad, Maria

Ruzhnikov, Maura R. Z.

Samadi, Mehrzad

Sethia, Ankit

Spiteri, Elizabeth

Wright, Christopher J.

Xiong, Katherine http://orcid.org/0000-0002-1603-2037
Zhu, Tong

Jain, Miten

Sedlazeck, Fritz J. http://orcid.org/0000-0001-6040-2691
Carroll, Andrew http://orcid.org/0000-0002-4824-6689
Paten, Benedict http://orcid.org/0000-0001-8863-3539
Ashley, Euan A. http://orcid.org/0000-0001-9418-9577
License Information

Text and Data Mining valid from 2022-03-28

Version of Record valid from 2022-03-28
More Information

Article History

Received: 23 June 2021

Accepted: 13 January 2022

First Online: 28 March 2022

Competing interests

: J.E.G. owns stock in INVITAE, Illumina and PacBio. K.S. has performed paid internships at NVIDIA Corp. and Google LLC, and presented a talk at an ONT-sponsored event. P.C., G.B, A.K., M.N. and A.C. are employees of Google LLC and own Alphabet stock as part of the standard compensation package. D.R.G., J.G. and C.J.W. are employees of Oxford Nanopore Technologies and share/share option holders. M.S., A.S. and T.Z. are employees of NVIDIA Corp. and own NVIDIA stock as part of the standard compensation package. M.J. has received reimbursement for travel, accommodation and conference fees to speak at events organized by ONT. F.J.S. received travel compensation from Pacific Biotechnology and Oxford Nanopore Technologies. E.A.A. is cofounder of Personalis, Deepcell, and Svexa, Advisor to Apple, and a Non-Executive Director of AstraZeneca. The remaining authors declare no competing interests.

Document is current

Any future updates will be listed below